FDA-Inspected Site

QuVa Pharma, Inc.

4 FDA inspections are on record for QuVa Pharma, Inc. in Bloomsbury, United States.

483· Form 483 issued

Bloomsbury, United States · Last updated July 9, 2026

Overview

  • 4 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-04-04.

At a glance

Inspections

4

Form 483s

4

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
25 Mar 2025 – 4 Apr 2025Human Drugs483View 483 →
16 Aug 2022 – 14 Oct 2022Human DrugsWLOn file
7 May 2019 – 31 May 2019Human Drugs483View 483 →
13 Nov 2017 – 30 Nov 2017Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

4 Apr 2025
21 CFR 211.165(d)

Acceptance/Rejection Levels

Cited by Logan T Williams

4 Apr 2025
21 CFR 211.165(e)

Test methods

Cited by Logan T Williams

4 Apr 2025
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Logan T Williams

4 Apr 2025
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Logan T Williams

4 Apr 2025
21 CFR 211.56(b)

Written sanitation procedures not followed

Cited by Logan T Williams

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.56(b)Cited across public-safe Form 483 observations2x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.188(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind QuVa Pharma, Inc.'s 4 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat